Hagopian Henry III
Known title: Chief Financial OfficerCIK: 0001821822
Associated companies
Transaction History
| ANVS | ▲ Buy | Grant | 824 | $5K | 11/20/2023 | View on chart |
| ANVS | ▲ Buy | Grant | 1,000 | $13K | 4/7/2023 | View on chart |
| ANVS | ▲ Buy | Grant | 824 | $5K | 11/20/2023 | View on chart |
| ANVS | ▲ Buy | Grant | 1,000 | $13K | 4/7/2023 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Annovis Bio Partners with Weave Bio for Alzheimer's NDA
Annovis Bio has announced a partnership with Weave Bio to use an AI regulatory platform. This collaboration is aimed at preparing the New Drug Application for buntanetap, a treatment for Alzheimer’s disease. The move supports the company's efforts to advance its lead candidate through the regulatory process.
Annovis Bio Partners with Weave Bio for Alzheimer's NDA. Annovis Bio has announced a partnership with Weave Bio to use an AI regulatory platform. This collaboration is aimed at preparing the New Drug Application for buntanetap, a treatment for Alzheimer’s disease. The move supports the company's efforts to advance its lead candidate through the regulatory process.